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Effect of ovulation induction on QT dispersion in electrocardiography
Ayla ÜÇKUYU1, Faika Ceylan ÇİFTÇİ1, Özgür ÇİFTÇİ2, Emel Ebru ÖZÇİMEN1, Erzat TOPRAK1,
Erdem TURHAN1

Aim: To investigate whether ovulation induction resulting in supra-physiological concentration range of ovarian
hormones has an effect on interlead ventricular depolarization heterogeneity via QT dispersion measurements.
Estrogens influence the duration of cardiac repolarization but there is no significant change in the QT interval duration
within the range of physiological estradiol variations.
Materials and methods: Included in the study were 40 subjects, in whom ovulation induction was planned, and 20
volunteers. During the study, a 12-lead electrocardiogram of each woman was carried out 3 times: for the first time
on day 2-3 of the menstrual cycle (menstrual day), for the second time 36 h after hCG administration (ovulatory day),
and for the third time at 6-8 days following ovulation (mid-luteal day). The RR and QT wave distances were measured.
The QT interval corrected for heart rate (corrected QT) was calculated for each derivation. The difference between the
longest and shortest corrected QT intervals was determined as corrected QT dispersion.
Results: No difference was seen in the mean QT and corrected QT interval duration and the maximum corrected QT
interval duration between menstrual phases. On the ovulatory day at peak estrogen level, the corrected QT dispersion
was found to be lower than on mid-luteal and menstrual day.
Conclusion: QT dispersion demonstrates the regional repolarization heterogeneity of the myocardium, which reflects
the propensity of ventricular arrhythmia decreases on the ovulatory day of the ovulation induction cycle.
Key words: Estrogen, ventricular repolarization, ventricular arrhythmia, ovulation induction

Ovulasyon indüksiyonunun elektrokardiyografide QT dispersiyonu üzerine etkisi
Amaç: Overyan hormonların suprafizyolojik düzeylerde olduğu ovulasyon induksiyon tedavilerinin QTdispersiyon
ölçümü yoluyla ventrikül repolarizasyon heterojenitesi üzerine etkilerini araştırdık. Estrojenler kardiyak repolarizasyon
üzerine etki ederler, fakat fizyolojik estradiol değişikliklerinde QT interval süresinde önemli bir değişiklik görülmemiştir.
Yöntem ve gereç: Ovulasyon indüksiyonu planlanan kırk infertil hasta ve 20 sağlıklı gönüllü çalışmaya alındı. Çalışma
süresince kadınların 12 derivasyonlu elektrokardiyografi kayıtları 3 kez alındı; ilk olarak, menstrual siklusun 2-3ncü
günü (menstrual gün); ikinci kez hCG uygulamasından 36 saat sonra (ovulasyon günü); üçüncü kez ovulasyonu
takiben 6-8nci günde (midluteal gün) RR ve QT dalga mesafeleri ölçüldü. Kalp hızına göre düzeltilen QT intervali her
derivasyon için hesaplandı. En uzun ve en kısa düzeltilmiş QT intervalleri arasındaki fark düzeltilmiş QT dispersiyonu
olarak belirlendi.
Bulgular: Ortalama QT, ortalama düzeltilmiş QT interval süreleri ve maksimum düzeltilmiş QT interval sürelerinde
menstrual siklusun fazları arasında fark yoktu. En yüksek estradiol düzeyinin olduğu ovulasyon gününde düzeltilmiş
QT dispersiyonu midluteal ve menstrual günden daha düşük bulundu.
Sonuç: Myokardın bölgesel repolarizasyon heterojenitesini gösteren ve ventriküler aritmiye eğilimi yansıtan QT
dispersiyonu ovulasyon indüksiyon siklusunun ovulasyon gününde azalmaktadır.
Anahtar sözcükler: Estrojen, ventriküler repolarizasyon, ventriküler aritmi, ovulasyon indüksiyonu
Received: 27.10.2010 – Accepted: 11.02.2011
Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Konya – TURKEY
2
Department of Cardiology, Faculty of Medicine, Başkent University, Konya - TURKEY
Correspondence: Ayla ÜÇKUYU, Hocacihan M. Saray C. N: 1 Selçuklu, Konya - TURKEY
E-mail: uckuyuayla@gmail.com
1

491

Ovulation induction and QT dispersion

Introduction
In infertility treatment, ovulation induction has been
used for half a century. In treatment, numerous follicles
are developed in the ovaries in order to increase
the prospect of conception; hence, an exaggerated
cycle is formed. As a consequence of multifollicular
development, exposure to estrogen and other ovarian
hormones occurs at high doses, albeit for a short time.
During these treatments, follicular development and
intra-cycle hormonal alterations may be followed
closely.
Sex hormones are known to exert direct and
indirect effects on cardiovascular function (1). Sex
hormones also play a critical role in regulating cardiac
repolarization. The female sex is considered to be a
risk factor for ventricular arrhythmias. Furthermore,
experimental studies have shown that estrogen has an
impact on the electrophysiological properties of the
heart. The female sex has been associated with a slower
rate of cardiac repolarization, i.e. a longer ECG QT
interval (2). It has been suggested that the resection of
ovaries shortens the QT interval, while estradiol and
dihydrotestosterone prolong it in the rabbit (3).
QT distance, which is defined as the time period
from the beginning of the Q wave to the return of
the T wave to the isoelectric line in an ECG, reflects
the period passing during depolarization and
repolarization of ventricles. QT interval refers to the
overall duration of the electrical activation and resting
of the ventricle, corresponding to the location of each
lead, and is inversely correlated with the heart rate.
QT dispersion is defined as the difference between the
longest and shortest QT interval measured in a 12-lead
ECG (4).
It is accepted that QT dispersion shows regional
heterogeneity
in
myocardial
repolarization.
Nonhomogeneous myocardial repolarization time is
explained by the delay in the action potential period
due to the slowing of regional conduction or change in
the conduction path. A higher QT dispersion means
a higher heterogeneity in ventricular repolarization
and, therefore, the higher the ventricular instability
(5). Nonhomogeneous conduction velocity in different
regions of ventricles, i.e. increase in QT dispersion,
may lead to serious ventricular arrhythmias and,
hence, sudden cardiac death (6). It is thought that
homogeneity of overall duration of ventricular
depolarization and repolarization (namely low QT
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dispersion) has a protective effect against arrhythmias.
Prolongation of the QT interval and QT dispersion
independently negatively affected the prognosis,
cardiovascular mortality, and cardiac morbidity in a
general population over 11 years (7).
The purpose of this study was to investigate whether
ovulation induction brings about any changes in the
QT interval and QT dispersion, which is considered
a noninvasive method of measuring regional
repolarization inhomogeneity, and to study their
relation to circulating concentrations of sex hormones.
Materials and methods
Subjects
Included in the present prospective study were 40
infertile women, aged between 23 and 35, who were
referred to the infertility clinic of Başkent University
Obstetrics and Gynecology Department, from
September 2008 to March 2009, in whom ovulation
induction was planned and 20 age-matched healthy
women with regular menstrual cycle. They had
no cardiac or neurological symptoms nor did they
smoke or take cardiovascular medications or any
other drugs. All of the women gave written informed
consent to the study protocol, which was approved
by the local Ethics Committee. Patients with mild
male factor or unexplained infertility and in whom
ovulation induction and intrauterine insemination
were planned were included in the study. Exclusion
criteria were as follows: evidence or history of heart
disease, hypertension, diabetes, thyroid disease, severe
menstrual disorders (amenorrhea, anovulation, etc.)
connective tissue disease, or renal disease.
Ovulation induction protocol
On day 2 or 3 of the natural cycle, all patients were
examined with a transvaginal ultrasound and the total
antral follicles were counted in both ovaries. Patients
who did not have residue cysts over 10 mm and whose
serum E2 levels were <60 pg/mL, FSH <8 mIU/mL,
and LH <8 mIU/mL were instituted with the ovulation
induction treatment on the same day. Stimulation
with recombinant follicle-stimulating hormone (rec
FSH) (Puregon, Organon, İstanbul, Turkey) at 50-100
IU/day was initiated and maintained for 8-10 days
with adjustments made according to the response
of the ovary to the dose. When at least one leading
follicle reached a diameter of 18 mm, 250 μg of rhCG
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(Ovitrelle; Serono, İstanbul, Turkey) was administered
subcutaneously to trigger ovulation and the final
stage of follicular maturation. Dominant follicles were
counted ultrasonographically on the same day. On
day 3 after the triggering of ovulation, micronized
progesterone was initiated vaginally (Progestan;
Koçak, İstanbul, Turkey) at the dose of 600 mg/day and
administered for 12 days.
Experimental design
Each participant underwent a physical examination
before participating in the study. Their ECG was
recorded 3 times during the menstrual cycle. ECG
records were taken for the first time on day 2-3 of
the natural menstruation cycle (menstrual day),
for the second time 36 h after hCG administration,
when ovulation occurred and immediately before
the insemination procedure (ovulatory day), and for
the third time 6-8 days after ovulation (mid-luteal
day). To minimize the instant varieties, 3 consecutive
ECG records were also taken at half hour intervals,
as mentioned above, on each day of the menstrual
cycle. The average of measurements obtained from
the 3 consecutive ECG records was considered as the
measurement of that day of menstrual cycle. Serum
E2 and progesterone levels of the patients were also
measured on the 3 days of the menstrual cycle.
All patients underwent 12-lead ECG examinations
following 10 min rest and holding their breath at 10
mm/mV amplitude and 25 mm/s rate. After the ECG
records were transferred to digital media, they were
magnified on a high resolution monitor and the heart
rate, RR, and QT wave distances were measured.
All electrocardiograms were analyzed by a single
observer blinded to the clinical data. The QT interval
was manually measured by using hand-held calipers
from the beginning of the QRS complex to the end of
the T-wave. The end of the T-wave was defined as the
intersection between a tangent to the terminal slope
of the T-wave and the PR baseline. Only monophasic
well defined T-waves were accepted for measurement.
If the end of the T-wave could not be identified because
of the low amplitude of the T-wave, then the lead was
excluded from analysis. If a U-wave was present, then
a tangential line was drawn on the terminal slope of the
T-wave and the end of the T-wave was determined as
the point of intersection of this line with the isoelectric
base. The QT interval and the preceding RR interval
were measured in 3 consecutive cycles. In each lead,

mean of the corrected QTc interval of 3 consecutive
beats was considered as the QTc interval of that lead.
Subjects with complete bundle branch block, atrial
fibrillation, second or third degree atrio-ventricular
block, or less than 9 measurable leads in the ECG were
excluded.
The heart rate-corrected QT interval (QTc,
millisecond (ms)) was calculated by using Bazett’s
formula [QTc = QT/√ (RR)] for each derivation (8,9).
The QTc dispersion (QTcd) (ms) was defined as the
absolute difference between the maximum (QTcmax)
and minimum (QTcmin) QTc interval in any of the
ECG leads. To determine the intraobserver variability
of QTc interval measurements, 20 randomly selected
electrocardiograms were analyzed by the same observer
at a different time. These recordings were also analyzed
by another observer to determine the interobserver
variability.
Statistical analyses
Statistical analyses were performed using SPSS (version
13.0, SPSS Inc, Chicago, IL, USA). Numeric values are
expressed as means ± SD. Comparisons study and
control groups were done with the Mann-Whitney
U-test. The difference between the electrocardiographic
parameters within the study group was assessed by
the paired-samples t test. When the parametric tests
were not appropriate, the Wilcoxon signed rank
test was used. P < 0.05 was considered statistically
significant. Pearson’s correlation analysis was used to
assess the correlation between hormone levels and
electrocardiographic parameters and to assess the
intra- and interobserver variability in the measurement
of the QTc interval.
Results
Demographic characteristics of the 40 infertile
women and 20 healthy women at menstrual phase are
demonstrated in Table 1. Both groups were similar
in their mean age, BMI, AFC, and other biochemical
parameters (Table 1). Blood pressure and heart rate
did not differ between groups or between menstrual
and ovulatory and mid-luteal day. No difference was
seen in terms of ECG findings of the women between
the control group and study group, who were all in the
menstrual phase (Table 2). In the study group, there was
a significant difference in terms of serum estradiol and
progesterone levels in each of the 3 days of the menstrual
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Table 1. Demographic characteristics and hormone levels of the study and control
subjects.

Parameters

Study group
N = 40

Control group
N = 20

P value

Age (years)

27.6 ± 5.6

29.7 ± 4.9

ns

BMI (kg/m²)

25.5 ± 3.6

27.6 ± 6.1

ns

AFC

30.2 ± 16.5

20.4 ± 4.7

ns

DFC

3.1 ± 2.1

Hemoglobin (g/dL)

12.5 ± 1.7

12.3 ± 1.3

ns

FSH (mIU/mL)

6.3 ± 2.3

7.8 ± 6.5

ns

LH (mIU/mL)

5.2 ± 2.5

6.5 ± 3.4

ns

TSH (mU/mL)

1.3 ± 0.7

1.7 ± 2.1

ns

AFC: Antral follicle count (on menstruation), DFC: Dominant follicle count (on
ovulation), BMI: Body mass index, TSH: Thyroid stimulating hormone, FSH: Follicle
stimulating hormone, and LH: Luteinizing hormone. All values are mean ± SD.
Table 2. Concentrations of sex hormones and electrocardiographic results of patients.

Parameters

Control group N = 20

Study group N = 40

Menstrual day

Menstrual day

Ovulatory day

Mid-luteal day

86.6 ± 46.9

36.2 ± 15.6º

684.1 ± 219.8u

389.3 ± 242.7m

0.8 ± 0.5

0.5 ± 0.2

1.1 ± 1.2

35.1 ± 11.2m o

QTc max (ms)

428.3 ± 21.1

427.6 ± 16.5

418.6 ± 16.3

417.2 ± 34.5

QTc min (ms)

361.1 ± 22.4

365.7 ± 18.5

371.3 ± 21.1u

354.5 ± 20.9m

QTc mean (ms)

396.3 ± 12.7

395.1 ± 14.4

395.7 ± 14.5

394.6 ± 14.3

Estradiol (pg/mL)
Progesterone (ng/mL)

mu

QTc dispersion (ms)

53.1 ± 18.8

61.9 ± 14.2

47.7 ± 12.6

62.8 ± 13.1

QT mean (ms)

347.6 ± 15.3

342.8 ± 14.6

346.7 ± 12.9

345.1 ± 11.9

Heart rate (beats/min)

69.8 ± 11.7

73.8 ± 9.4

74.6 ± 7.5

69.9 ± 8.5

Systolic BP (mmHg)

120.4 ± 4.8

119.4 ± 10.7

121.4 ± 9.6

118.5 ± 7.6

Diastolic BP (mmHg)

73.8 ± 12.9

69.5 ± 9.7

67.7 ± 11.5

71.2 ± 8.2

QTc: corrected QT interval, ms: millisecond, and BP: blood pressure. All values are mean ± SD.
vs. Ovulatory day P < 0.05
m
vs. Menstrual day P < 0.05
u
vs. Mid-luteal day P < 0.05
o

cycle. There was no difference between menstrual and
ovulatory and mid-luteal day with regard to mean
QTc interval duration and maximum QTc interval
duration. On the ovulatory day with peak estrogen
level, QTc dispersion was lower than that on the mid494

luteal and menstrual days (Table 2). Minimum QTc
interval duration was found to be longest on ovulatory
day and shortest on mid-luteal day. When Pearson
correlation analysis was carried out, no correlation was
found between serum hormone levels at the 3 phases of
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menstrual cycle and QTc interval and QTc dispersion.
Both interobserver and intraobserver variabilities were
<5% for all of the electrocardiographic variables. On
each day, the intracycle variability was <7% for all of
the measurements.
Discussion
This is the first study investigating the relation between
QT dispersion, which reflects the tendency for
arrhythmia, and the hormone levels of infertile women
experiencing an exaggerated menstrual cycle with
ovulation induction. At present, an increasing number
of women demand infertility treatment without any
hesitation. We do not have much information on
the probable cardiac effects of ovulation induction
treatments.
There are conflicting results regarding the
alterations in the QT interval duration during
the menstrual cycle with fluctuations in hormone
levels. Hulot et al. observed no significant change in
the QT interval duration within the large range of
physiological estradiol variations found during the
menstrual cycle (10). Nakagawa et al. found a shorter
QT interval during the luteal phase than during the
follicular phase, contrary to other investigations (11).
They investigated the effects of the menstrual cycle on
the QT interval dynamics but not the QT dispersion
via holter ECGs and the autonomic tone in 11 healthy
women (11). In the present study, in the ovulation
induction cycle, during menstrual cycle when ovulation
and luteinization is clearly shown, the QT interval and
the QTc interval duration was investigated during an
ECG. No change was seen in the QT and QTc intervals
between different phases of the cycle.
The ovulation induction treatments with mild
stimulation, in which mean 3 follicles are developed,
are closer to the natural menstrual physiology.
Follicular development can be clearly observed during
the treatment and intra cycle hormonal alterations and
peak hormone days can be also determined. Studies on
ovulation induction cycles, when the cycle is closely
monitored, as in our study, may show the effect of
ovarian hormones on the heart better than studies
carried out with spontaneous menstrual cycles.
Human studies have been insufficient in showing
the effect of estrogen on ventricular repolarization. In

the present study, consistent with the findings of Saba
et al. that HRT with estrogen significantly decreases
the QT dispersion (12), the QTc dispersion was found
to be decreased in the high estrogen level period. In the
mid-luteal period, when estrogen partially decreases
and progesterone peaks, the QTc dispersion was at
the same level as that in the menstrual period, which
may be a mechanism mediating the protective effect of
estrogen on heart.
The most important advantage of the QT dispersion
is that it shows the risk of ventricular arrhythmia with
an easily applied noninvasive method. In manual
measurements, interobserver and intraobserver
differences may restrict the accuracy of measurements
(6). Automated measurement methods have been
developed for the QT interval with lower rates of
error than manual measurements. However, in the
automated measurements, there are also errors related
to methodology and they are not much superior
to the manual method (13). In the present study,
measurements were made in a digital environment
with high resolution, manually.
In
many
clinical
studies
investigating
noncardiologic patients, the prognostic significance of
the QT interval and QT dispersion was demonstrated.
These studies examine patients with Type I DM (14),
anorexia nervosa (15), CO poisoning (16), ankylosing
spondylitis (17), electrolyte disturbances (18),
undergoing dialysis (18) and renal transplant (19),
severe burns (20), and professional athletes with left
ventricle hypertrophy (21).
The present study has several limitations. First,
although QT dispersion is a widely used index, its real
predictive value remains questionable. The principal
technical problem is the method used to identify
the end of the T wave (6). Second, women with
infertility problems constitute a patient group with
high anxiety levels associated with the duration of
infertility and the history of pregnancy loss. Therefore,
electrocardiographic changes may be evaluated
administering anxiety scales. The duration of ovulation
induction and the number of repeated cycles may
enhance anxiety and may lead to different results.
Third, in this study, we found that the QT dispersion
decreased in patients undergoing mild stimulation for
planned ovulation induction. However, in different
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populations such as in patients with an IVF cycle in
which much higher estrogen levels are attained or in
patients with ovarian hyperstimulation syndrome,
the QT dispersion measurements may be found to
be different from our results. Finally, in the present
study, QT measurements were obtained from healthy
subjects (no cardiovascular, metabolic, or neurologic
disease) and need to be confirmed in other high risk
population groups.

Conclusion
QT dispersion demonstrating the regional
repolarization heterogeneity of the myocardium, which
reflects the propensity to cardiac arrhythmia decreases
in the ovulation phase of the cycle, with peak estrogen
levels in the ovulation induction cycles with mild
stimulation. Our results may show the safety of the
elevation of sex steroids on ventricular repolarization
heterogeneity.
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